Trademark: 90265504
Status Date
Friday, December 16, 2022
Filing Date
Tuesday, October 20, 2020
Published for Opposition
Tuesday, May 4, 2021
42 Development of pharmaceutical preparations for gene therapy; development of platform technology, namely, gene therapy platforms for manufacturing therapeutics; scientific research services, namely, collection of specific molecular and genomic data for analytical and clinical purposes; providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Mar 10, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Mar 10, 2023
Teas Change Of Correspondence Received
Mar 10, 2023
Teas Change Of Owner Address Received
Dec 20, 2022
Notice Of Approval Of Extension Request E-Mailed
Dec 16, 2022
Sou Extension 3 Granted
Dec 16, 2022
Sou Extension 3 Filed
Dec 16, 2022
Teas Extension Received
Jun 2, 2022
Notice Of Approval Of Extension Request E-Mailed
May 31, 2022
Sou Extension 2 Granted
May 31, 2022
Sou Extension 2 Filed
May 31, 2022
Teas Extension Received
Dec 21, 2021
Notice Of Approval Of Extension Request E-Mailed
Dec 17, 2021
Sou Extension 1 Granted
Dec 17, 2021
Sou Extension 1 Filed
Dec 17, 2021
Teas Extension Received
Jun 29, 2021
Noa E-Mailed - Sou Required From Applicant
May 4, 2021
Official Gazette Publication Confirmation E-Mailed
May 4, 2021
Published For Opposition
Apr 14, 2021
Notification Of Notice Of Publication E-Mailed
Mar 26, 2021
Approved For Pub - Principal Register
Mar 20, 2021
Assigned To Examiner
Dec 8, 2020
New Application Office Supplied Data Entered
Oct 23, 2020
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
